1. Dai G, Levy O, Carrasco N (1996) Cloning and characterization of the thyroid iodide transporter. Nature 379: 458-460.
2. Carrasco N (1993) Iodide transport in the thyroid gland. Biochim Biophys Acta 1154: 65-82.
3. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, et al. (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24: 48-77.
4. Portulano C, Paroder-Belenitsky M, Carrasco N (2014) The Na+/I- symporter (NIS): mechanism and medical impact. Endocr Rev 35: 106-149.
5. Fujiwara H, Tatsumi K, Miki K, Harada T, Miyai K, et al. (1997) Congenital hypothyroidism caused by a mutation in the Na+/I- symporter. Nat Genet 16: 124-125.
6. Matsuda A, Kosugi S (1997) A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82: 3966-3971.
7. Bizhanova A, Kopp P (2009) Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 150: 1084-1090.
8. Wu SL, Ho TY, Liang JA, Hsiang CY (2008) Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter. J Endocrinol 199: 213-219.
9. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, et al. (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411-422.
10. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, et al. (2000) Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141: 839-845.
11. Bidart JM, Mian C, Lazar V, Russo D, Filetti S, et al. (2000) Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab 85: 2028-2033.
12. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP (1999) The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 21: 440-443.
13. Yoshida A, Taniguchi S, Hisatome I, Royaux IE, Green ED, et al. (2002) Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metab 87: 3356- 3361.
14. Yoshida A, Hisatome I, Taniguchi S, Sasaki N, Yamamoto Y, et al. (2004) Mechanism of iodide/chloride exchange by pendrin. Endocrinology 145: 4301-4308.
15. Wemeau JL, Kopp P (2017) Pendred syndrome. Best Pract Res Clin Endocrinol Metab 31: 213-224.
16. Ishii J, Suzuki A, Kimura T, Tateyama M, Tanaka T, et al. (2019) Congenital goitrous hypothyroidism is caused by dysfunction of the iodide transporter SLC26A7. Commun Biol 2: 270.
17. Cangul H, Liao XH, Schoenmakers E, Kero J, Barone S, et al. (2018) Homozygous loss-of-function mutations in SLC26A7 cause goitrous congenital hypothyroidism. JCI Insight 3.
18. Zou M, Alzahrani AS, Al-Odaib A, Alqahtani MA, Babiker O, et al. (2018) Molecular analysis of congenital hypothyroidism in Saudi Arabia: SLC26A7 mutation is a novel defect in thyroid dyshormonogenesis. J Clin Endocrinol Metab 103: 1889-1898.
19. Petrovic S, Barone S, Xu J, Conforti L, Ma L, et al. (2004) SLC26A7: a basolateral Cl-/HCO3- exchanger specific to intercalated cells of the outer medullary collecting duct. Am J Physiol Renal Physiol 286: F161-169.
20. Brommage R, Liu J, Hansen GM, Kirkpatrick LL, Potter DG, et al. (2014) High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes. Bone Res 2: 14034.
21. Kondo T, Nakamura N, Suzuki K, Murata S, Muramatsu A, et al. (2003) Expression of human pendrin in diseased thyroids. J Histochem Cytochem 51: 167-173.
22. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, et al. (1997) Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138: 2227-2232.
23. Riedel C, Levy O, Carrasco N (2001) Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276: 21458-21463.
24. Kogai T, Taki K, Brent GA (2006) Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Relat Cancer 13: 797-826.
25. Endo T, Kaneshige M, Nakazato M, Ohmori M, Harii N, et al. (1997) Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/I- symporter gene. Mol Endocrinol 11: 1747-1755.
26. Bizhanova A, Chew TL, Khuon S, Kopp P (2011) Analysis of cellular localization and function of carboxy-terminal mutants of pendrin. Cell Physiol Biochem 28: 423-434.
27. Pesce L, Bizhanova A, Caraballo JC, Westphal W, Butti ML, et al. (2012) TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells. Endocrinology 153: 512-521.
28. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, et al. (1998) Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci USA 95: 8251-8256.
29. Oda K, Luo Y, Yoshihara A, Ishido Y, Sekihata K, et al. (2017) Follicular thyroglobulin induces cathepsin H expression and activity in thyrocytes. Biochem Biophys Res Commun 483: 541-546.
30. Yoshihara A, Hara T, Kawashima A, Akama T, Tanigawa K, et al. (2012) Regulation of dual oxidase expression and H2O2 production by thyroglobulin. Thyroid 22: 1054-1062.
31. Suzuki K, Mori A, Saito J, Moriyama E, Ullianich L, et al. (1999) Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology 140: 5422-5430.
32. Yoshihara A, Luo Y, Ishido Y, Usukura K, Oda K, et al. (2019) Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes. Endocr J 66: 349-357.
33. Ishido Y, Yamazaki K, Kammori M, Sugishita Y, Luo Y, et al. (2014) Thyroglobulin suppresses thyroid-specific gene expression in cultures of normal but not neoplastic human thyroid follicular cells. J Clin Endocrinol Metab 99: E694-702.
34. Akama T, Sue M, Kawashima A, Wu H, Tanigawa K, et al. (2012) Identification of microRNAs that mediate thyroid cell growth induced by TSH. Mol Endocrinol 26: 493-501.
35. Sellitti DF, Puggina E, Lagranha C, Doi S, Pithon-Curi T, et al. (2007) TGF-beta-like transcriptional effects of thyroglobulin (Tg) in mouse mesangial cells. Endocr J 54: 449-458.
36. Suzuki K, Kohn LD (2006) Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J Endocrinol 189: 247-255.
37. Kogai T, Curcio F, Hyman S, Cornford EM, Brent GA, et al. (2000) Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol 167: 125-135.
38. Fradkin JE, Cook GH, Kilhoffer MC, Wolff J (1982) Forskolin stimulation of thyroid adenylate cyclase and cyclic 3',5'-adenosine monophosphate accumulation. Endocrinology 111: 849-856.
39. Civitareale D, Castelli MP, Falasca P, Saiardi A (1993) Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol Endocrinol 7: 1589-1595.
40. Francis-Lang H, Price M, Polycarpou-Schwarz M, Di Lauro R (1992) Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol 12: 576-588.
41. Tuncel M (2017) Thyroid stimulating hormone receptor. Mol Imaging Radionucl Ther 26: 87-91.
42. Kogai T, Brent GA (2012) The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics. Pharmacol Ther 135: 355-370.
43. Pomerance M, Abdullah HB, Kamerji S, Correze C, Blondeau JP (2000) Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, rac1, and reactive oxygen species. J Biol Chem 275: 40539- 40546.
44. Pesce L, Kopp P (2014) Iodide transport: implications for health and disease. Int J Pediatr Endocrinol 2014: 8.
45. Dentice M, Luongo C, Elefante A, Ambrosio R, Salzano S, et al. (2005) Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol Cell Biol 25: 10171-10182.
46. Medina DL, Suzuki K, Pietrarelli M, Okajima F, Kohn LD, et al. (2000) Role of insulin and serum on thyrotropin regulation of thyroid transcription factor-1 and pax-8 genes expression in FRTL-5 thyroid cells. Thyroid 10: 295-303.
47. Rotman-Pikielny P, Hirschberg K, Maruvada P, Suzuki K, Royaux IE, et al. (2002) Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum Mol Genet 11: 2625- 2633.
48. Aravind L, Koonin EV (2000) The STAS domain - a link between anion transporters and antisigma-factor antagonists. Curr Biol 10: R53-55.
49. Shibagaki N, Grossman AR (2006) The role of the STAS domain in the function and biogenesis of a sulfate transporter as probed by random mutagenesis. J Biol Chem 281: 22964-22973.